Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 53.30K | 24.20K | 35.00K | 14.90K | 74.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 53.30K | 24.20K | 35.00K | 14.90K | 74.20K |
| Cost of Revenue | 10.50K | 8.10K | 4.50K | 19.40K | 7.80K |
| Gross Profit | 42.80K | 16.10K | 30.40K | -4.50K | 66.40K |
| SG&A Expenses | 138.60K | 90.80K | 153.40K | 137.30K | 126.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 149.10K | 99.00K | 157.90K | 156.70K | 133.90K |
| Operating Income | -95.90K | -74.80K | -123.00K | -141.80K | -59.60K |
| Income Before Tax | -117.00K | -82.60K | -211.70K | -192.40K | -79.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -117.00K | -82.60K | -211.70K | -192.40K | -79.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.00K | -82.60K | -211.70K | -192.40K | -79.50K |
| EBIT | -95.90K | -74.80K | -123.00K | -141.80K | -59.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 11.63B | 11.63B | 11.14B | 10.73B | 10.50B |
| Average Diluted Shares Outstanding | 11.63B | 11.63B | 11.14B | 10.73B | 10.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |